Literature DB >> 8305877

Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells.

A Kukita1, T Kukita, K Hata, K Kurisu, O Kohashi.   

Abstract

To study the effects of osteoblast products on osteoclast formation, we added the conditioned medium (CM) of rat osteoblastic cell line ROS17/2.8 to rat bone marrow cultures, in which tartrate-resistant acid phosphatase (TRAP)-positive osteoclast-like multinucleate cells (MNCs) formed in the presence of 10(-8) M 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). The formation of 1,25(OH)2D3-dependent TRAP-positive MNC at day 7 of culture was strongly inhibited by the > 10 kDa fraction of ROS17/2.8 cell-CM (ROSCM), but heat treated ROSCM (htROSCM) expressed marked stimulation in the formation of the MNCs. The expression of several osteoclastic phenotypes of the MNCs induced by htROSCM and 1,25(OH)2D3 was more enhanced compared with that of the MNCs induced by 1,25(OH)2D3 alone. The MNCs induced by htROSCM and 1,25(OH)2D3 were highly motile, were sensitive to calcitonin (CT), and had high bone resorbing activity. These data suggest that htROSCM promotes the osteoclast differentiation in the presence of 1,25(OH)2D3 in a rat bone marrow culture system. The stimulatory activity of TRAP-positive MNC formation in htROSCM is derived from heat-stable protein(s) that is (are) thought to be different from colony-stimulating factors (CSFs) such as macrophage-CSF (M-CSF) or granulocyte-macrophage-CSF (GM-CSF).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305877     DOI: 10.1016/s0169-6009(08)80048-7

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  7 in total

1.  Regulation of osteoclastogenesis by Simon extracts composed of caffeic acid and related compounds: successful suppression of bone destruction accompanied with adjuvant-induced arthritis in rats.

Authors:  Quan Yong Tang; Toshio Kukita; Yuki Ushijima; Akiko Kukita; Kengo Nagata; Ferry Sandra; Toshiyuki Watanabe; Kazuko Toh; Yutaka Okuma; Sadamichi Kawasaki; Linda Rasubala; Junpei Teramachi; Ichiko Miyamoto; Zhou Wu; Tadahiko Iijima
Journal:  Histochem Cell Biol       Date:  2005-10-05       Impact factor: 4.304

2.  Regulation of osteoclastogenesis through Tim-3: possible involvement of the Tim-3/galectin-9 system in the modulation of inflammatory bone destruction.

Authors:  Kanako Moriyama; Akiko Kukita; Yin-Ji Li; Norihisa Uehara; Jing-Qi Zhang; Ichiro Takahashi; Toshio Kukita
Journal:  Lab Invest       Date:  2014-09-29       Impact factor: 5.662

3.  Fibroblasts from the inner granulation tissue of the pseudocapsule in hips at revision arthroplasty induce osteoclast differentiation, as do stromal cells.

Authors:  H Sakai; S Jingushi; T Shuto; K Urabe; T Ikenoue; K Okazaki; T Kukita; A Kukita; Y Iwamoto
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

4.  Mesenchymal stem cells markedly suppress inflammatory bone destruction in rats with adjuvant-induced arthritis.

Authors:  Toshio Takano; Yin-Ji Li; Akiko Kukita; Takayoshi Yamaza; Yasunori Ayukawa; Kanako Moriyama; Norihisa Uehara; Hisayuki Nomiyama; Kiyoshi Koyano; Toshio Kukita
Journal:  Lab Invest       Date:  2014-01-06       Impact factor: 5.662

5.  Adenosine blocks aminopterin-induced suppression of osteoclast differentiation.

Authors:  Junpei Teramachi; Akiko Kukita; Pengfei Qu; Naohisa Wada; Yin-Ji Li; Seiji Nakamura; Toshio Kukita
Journal:  J Bone Miner Metab       Date:  2012-11-01       Impact factor: 2.626

6.  Characterization and identification of subpopulations of mononuclear preosteoclasts induced by TNF-α in combination with TGF-β in rats.

Authors:  Rei Matsubara; Toshio Kukita; Yuka Ichigi; Ippei Takigawa; Peng-Fei Qu; Noboru Funakubo; Hiroshi Miyamoto; Kazuaki Nonaka; Akiko Kukita
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

Review 7.  The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis.

Authors:  Wessam E Sharaf-Eldin; Nourhan Abu-Shahba; Marwa Mahmoud; Nagwa El-Badri
Journal:  Stem Cells Int       Date:  2015-12-28       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.